Sichenzia Ross Ference LLP Represents A.G.P/ Alliance Global Partners in $6.5 Million Public Offering for Cellect Biotechnology Ltd.
Press Release – New York, NY – February 12, 2019 – Sichenzia Ross Ference LLP announced today that it represented A.G.P/ Alliance Global Partners as sole book running manager in the underwritten public offering of American Depository Shares (ADSs) and Warrants of Cellect Biotechnology Ltd., an Israeli biotech company (NASDAQ: APOP). National Securities Corporation and Dawson James Securities, Inc. acted as co-managers for the offering.
The offering consisted of an aggregate of 1,889,000 units, with each unit consisting of one ADS and a warrant to purchase one ADS as well as 2,444,800 pre-funded units consisting of one pre-funded warrant and one warrant for aggregate proceeds of $6.5 million. The effective price of each unit was $1.50. Cellect has developed a breakthrough technology for the selection of stem cells from tissue that aims to improve a variety of stem cell based therapies. The Sichenzia Ross Ference team was led by partners Gregory Sichenzia and Avital Perlman, Counsel Jeff Cahlon and associate Grant Levine.
Visit SRF's LinkedIn page
Latest posts by Sichenzia Ross Ference LLP (see all)
- Sichenzia Ross Ference LLP Represents Genetic Technologies Limited (ASX: GTG; Nasdaq: GENE) in Offering of $1.2 Million American Depositary Shares - May 24, 2019
- Sichenzia Ross Ference LLP Represents Aegis Capital Corp. in $8.0 Million Public Offering of Common Stock of Medalist Diversified REIT, Inc. - May 14, 2019
- Founding Partner Gregory Sichenzia to Moderate Cannabis Investor Panel - May 10, 2019